Total Bangun Persada Tbk PT
IDX:TOTL
Total Bangun Persada Tbk PT
IDX:TOTL
Price:
705
IDR
-2.76%
Market Closed
Market Cap:
2.4T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
TOTL Alert
Total Bangun Persada Tbk PT
705
-20 (-2.76%)
| 52 Week Range |
362
830
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Total Bangun Persada Tbk PT
Balance Sheet
Balance Sheet Decomposition
Total Bangun Persada Tbk PT
Total Bangun Persada Tbk PT
| Current Assets | 2.5T |
| Cash & Short-Term Investments | 1.2T |
| Receivables | 1.1T |
| Other Current Assets | 172.8B |
| Non-Current Assets | 794.3B |
| Long-Term Investments | 465.5B |
| PP&E | 110.6B |
| Intangibles | 1.4B |
| Other Non-Current Assets | 216.8B |
| Current Liabilities | 2T |
| Accounts Payable | 160.5B |
| Accrued Liabilities | 1.2T |
| Other Current Liabilities | 637.3B |
| Non-Current Liabilities | 173.9B |
| Other Non-Current Liabilities | 173.9B |
Balance Sheet
Total Bangun Persada Tbk PT
Total Bangun Persada Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
81 985
|
101 884
|
73 556
|
46 020
|
39 723
|
66 256
|
99 027
|
109 740
|
159 909
|
249 382
|
|
| Cash |
81 985
|
101 884
|
73 556
|
46 020
|
39 723
|
66 256
|
99 027
|
109 740
|
159 909
|
249 382
|
|
| Short-Term Investments |
563 886
|
706 652
|
694 701
|
792 226
|
794 872
|
788 634
|
675 868
|
859 378
|
1 009 130
|
714 308
|
|
| Total Receivables |
1 034 579
|
1 051 398
|
1 128 860
|
1 309 899
|
1 509 365
|
1 258 001
|
1 311 053
|
983 862
|
1 043 118
|
1 421 059
|
|
| Accounts Receivables |
418 482
|
350 848
|
770 549
|
898 236
|
1 088 897
|
835 777
|
961 025
|
667 129
|
728 068
|
1 083 742
|
|
| Other Receivables |
616 096
|
700 549
|
358 311
|
411 663
|
420 468
|
422 224
|
350 028
|
316 732
|
315 050
|
337 316
|
|
| Inventory |
0
|
6 482
|
16 491
|
5 349
|
0
|
0
|
0
|
0
|
0
|
32 814
|
|
| Other Current Assets |
342 387
|
369 689
|
371 333
|
360 474
|
326 448
|
170 013
|
115 954
|
98 052
|
110 405
|
87 247
|
|
| Total Current Assets |
2 022 837
|
2 236 105
|
2 284 941
|
2 513 967
|
2 670 409
|
2 282 904
|
2 201 902
|
2 051 031
|
2 322 562
|
2 504 811
|
|
| PP&E Net |
70 991
|
194 298
|
186 495
|
230 615
|
165 726
|
163 853
|
145 403
|
126 986
|
120 588
|
114 194
|
|
| PP&E Gross |
70 991
|
194 298
|
186 495
|
230 615
|
165 726
|
163 853
|
145 403
|
126 986
|
120 588
|
114 194
|
|
| Accumulated Depreciation |
112 237
|
131 476
|
158 101
|
185 226
|
190 606
|
212 945
|
237 667
|
251 718
|
251 692
|
256 538
|
|
| Intangible Assets |
3 376
|
4 214
|
4 071
|
3 310
|
3 524
|
3 881
|
3 130
|
4 244
|
3 818
|
3 318
|
|
| Note Receivable |
0
|
0
|
0
|
978
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
106 662
|
92 385
|
140 529
|
164 414
|
95 234
|
258 262
|
279 493
|
244 806
|
361 720
|
324 463
|
|
| Other Long-Term Assets |
279 880
|
319 150
|
334 523
|
329 811
|
293 824
|
254 094
|
259 131
|
300 239
|
181 739
|
185 786
|
|
| Total Assets |
2 483 746
N/A
|
2 846 153
+15%
|
2 950 560
+4%
|
3 243 093
+10%
|
3 228 718
0%
|
2 962 994
-8%
|
2 889 060
-2%
|
2 727 307
-6%
|
2 990 427
+10%
|
3 132 572
+5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
69 916
|
154 461
|
188 935
|
236 868
|
213 867
|
162 142
|
133 851
|
110 238
|
153 422
|
207 397
|
|
| Accrued Liabilities |
513 834
|
628 516
|
697 631
|
883 864
|
869 095
|
687 292
|
756 124
|
684 117
|
844 345
|
1 105 435
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
21 841
|
15 956
|
8 632
|
9 858
|
0
|
0
|
2 084
|
160
|
0
|
0
|
|
| Other Current Liabilities |
974 171
|
978 107
|
888 973
|
863 412
|
862 629
|
755 288
|
584 798
|
500 514
|
566 242
|
571 175
|
|
| Total Current Liabilities |
1 557 920
|
1 777 040
|
1 784 172
|
1 994 003
|
1 945 591
|
1 604 723
|
1 476 858
|
1 295 029
|
1 564 009
|
1 884 007
|
|
| Long-Term Debt |
0
|
23 644
|
16 999
|
7 141
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1 790
|
17 684
|
17 379
|
4 129
|
2 115
|
2 340
|
2 648
|
2 692
|
2 542
|
2 517
|
|
| Other Liabilities |
157 977
|
179 154
|
206 778
|
231 850
|
231 016
|
281 367
|
273 038
|
200 393
|
186 243
|
181 498
|
|
| Total Liabilities |
1 717 687
N/A
|
1 997 522
+16%
|
2 025 328
+1%
|
2 237 124
+10%
|
2 174 493
-3%
|
1 883 750
-13%
|
1 747 247
-7%
|
1 492 730
-15%
|
1 747 710
+17%
|
2 062 988
+18%
|
|
| Equity | |||||||||||
| Common Stock |
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
341 000
|
|
| Retained Earnings |
415 442
|
504 541
|
591 158
|
682 225
|
720 393
|
759 720
|
825 563
|
893 144
|
899 574
|
731 256
|
|
| Additional Paid In Capital |
3 869
|
3 869
|
4 728
|
4 728
|
4 728
|
4 728
|
4 728
|
4 728
|
4 728
|
4 728
|
|
| Other Equity |
5 748
|
779
|
11 654
|
21 984
|
11 896
|
26 204
|
29 479
|
4 296
|
2 585
|
7 401
|
|
| Total Equity |
766 060
N/A
|
848 631
+11%
|
925 232
+9%
|
1 005 970
+9%
|
1 054 225
+5%
|
1 079 244
+2%
|
1 141 813
+6%
|
1 234 577
+8%
|
1 242 718
+1%
|
1 069 584
-14%
|
|
| Total Liabilities & Equity |
2 483 746
N/A
|
2 846 153
+15%
|
2 950 560
+4%
|
3 243 093
+10%
|
3 228 718
0%
|
2 962 994
-8%
|
2 889 060
-2%
|
2 727 307
-6%
|
2 990 427
+10%
|
3 132 572
+5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
3 410
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
